Drug Safety is the official journal of the International Society of Pharmacovigilance. The journal includes:   

Overviews of contentious or emerging issues. 
Comprehensive narrative reviews that provide an authoritative source of information on epidemiology, clinical features, prevention and management of adverse effects of individual drugs and drug classes. 
In-depth benefit-risk assessment of adverse effect and efficacy data for a drug in a defined therapeutic area. 
Systematic reviews (with or without meta-analyses) that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.
Original research articles reporting the results of well-designed studies in disciplines such as pharmacoepidemiology, pharmacovigilance, pharmacology and toxicology, and pharmacogenomics.
Editorials and commentaries on topical issues.

Editor (Adis International Limited, Auckland, New Zealand):
Nitin Joshi
Editorial Board:
G.C. Alexander, John Hopkins School of Public Health, Baltimore, MD, USA
L. Azoulay, McGill University, Montreal, QC, Canada
B. Bannwarth, Hospital Pellegrin-Tondu, Bordeaux, France
J. Barnes, University of Auckland, Auckland, New Zealand
D.W. Bates, Harvard Medical School, Boston, MA, USA
F.M.C Besag, National Health Service, Bedford, England
N. Buckley, University of Sydney, Sydney, NSW, Australia
R.O. Day, University of New South Wales, Darlinghurst, NSW, Australia
F. De Ponti, University of Bologna, Bologna, Italy
A.N.O. Dodoo, University of Ghana Medical School, Accra, Ghana
I.R. Edwards, Gothenburg, Sweden
A.C.G. Egberts, Utrecht University, Utrecht, the Netherlands
S.J.W. Evans, London School of Hygiene and Tropical Medicine, London, England
A. Figueiras, University of Santiago de Compostela, Santiago de Compostela, Spain
J. Gagne, Harvard Medical School, Boston, MA, USA
S.A. Goldman, Stephen A Goldman Consulting Services, Morris Plains, NJ, USA
A.J. Gordon, Pharmaceutical Consultant, Greenwich, CT, USA
S. Hägg, Linköping University, Linköping, Sweden
K.Y. Hartigan-Go, Asian Institute of Management, Manila, Philippines
L. Howes, Griffith University, Southport, QLD, Australia
D. Hunt, MRC Institute of Genetics and Molecular Medicine, Edinburgh, Scotland
S. Jick, Boston University School of Public Health, Lexington, MA, USA
S. Krähenbühl, University Hospital Basel, Basel, Switzerland
K. Kubota, NPO Drug Safety Research Unit Japan, Tokyo, Japan
J.-R. Laporte, Fundació Institut Català de Farmacologia, Barcelona, Spain
D. Layton, QuintilesIMS, and University of Portsmouth, Portsmouth, England
H. Le Louet, Henri Mondor University Hospital, Paris, France
J.H. Lewis, Georgetown University School of Medicine, Georgetown, DC, USA
M. Lindquist, The Uppsala Monitoring Centre, Uppsala, Sweden
Y.K. Loke, University of East Anglia, Norwich, England
C.R. Meier, University of Basel, Basel, Switzerland
R. Meijboom, University of Utrecht, Utrecht, the Netherlands
P.G.M. Mol, University Medical Center Groningen, Groningen, the Netherlands
J.-L. Montastruc, Université Toulouse III Paul Sabatier, Toulouse, France
N. Moore, Universite de Bordeaux, Bordeaux, France
G.N. Norén, The Uppsala Monitoring Centre, Uppsala, Sweden
M. Pirmohamed, University of Liverpool, Liverpool, England
R.L. Savage, New Zealand Pharmacovigilance Centre, Dunedin, New Zealand
N. Shah, Stanford University School of Medicine, Stanford, CA, USA
R.R. Shah, Rashimi Shah Consultancy, Ltd., Gerrards Cross, England
S. Shakir, Drug Safety Research Unit, Southampton, Hampshire, England
N. Shear, University of Toronto, Toronto, ON, Canada
O. Spigset, St Olav's University Hospital, Trondheim, Norway
N.P. Tatonetti, Columbia University, New York, NY, USA
G. Trifirò, University of Messina, Messina, Italy
M. Tuccori, University Hospital of Pisa, Pisa, Italy
E.P. van Puijenbroek, Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, the Netherlands
L.V. Wilton, Southampton, England
I.C.K. Wong, UCL School of Pharmacy, London, England
L. Zhang, Beijing University of Chinese Medicine, Beijing, China